Cancer News and Research

Latest Cancer News and Research

New study linking pain relievers and breast cancer fails to convince experts

Research in recent years has consistently linked the use of aspirin and other anti-inflammatory pain relievers with a lower risk of colon cancer, but findings about the drugs' effect on breast-cancer risk have been very mixed with some studies suggesting that the pain relievers protect against breast cancer, while others have found no link.

1 Jun 2005

Hybridon collaborates to develop immune modulatory (IMO) compounds for asthma and allergy

Hybridon today announced it had entered into research collaboration and license agreements with Novartis for the discovery, optimization, development and commercialization of Toll-like receptor 9 (TLR9) drug candidates targeting asthma and allergy based on Hybridon's proprietary immune modulatory oligonucleotide (IMO) technology platform.

1 Jun 2005

Cancer patients have increased risk of cognitive dysfunction

Cancer patients may have an increased risk of cognitive dysfunction compared with individuals who have never had cancer, according to a new study in the June 1 issue of the Journal of the National Cancer Institute.

31 May 2005

Shorter course of 8 gray radiotherapy effective for palliation of painful bone metastases

A single treatment of 8 gray (Gy--a unit of measure of absorbed radiation dose) of radiation appears to be as effective in palliating painful bone metastases as the current U.S. standard treatment course of 30 Gy delivered in 10 daily treatments, according to a new study in the June 1 issue of the Journal of the National Cancer Institute.

31 May 2005

Environment factors can interact with genetics to increase disease risk

New research shows that exposure to harmful chemicals and drugs during critical developmental periods early in life may actually "reprogram" the way certain genes respond to the female hormone estrogen. This genetic reprogramming may determine whether people with a genetic predisposition for a disease actually develop the disease.

31 May 2005

New approach to inhibiting blood vessel growth or angiogenesis

A manmade protein with a tail of amino acids delivered to target cells can dramatically reduce blood vessel growth that obstructs vision or feeds a tumor, researchers have found.

31 May 2005

BMA Scotland response to McTear v Imperial Tobacco verdict

Commenting on the judgement announced by the Right Hon. Lord Nimmo Smith on the case of Mrs Margaret McTear against Imperial Tobacco Limited today (Tuesday 31 May 2005), Dr Bill O’Neill, Scottish Secretary of the British Medical Association (BMA), said:

31 May 2005

Health professionals should push for a total smoking

Health professionals should push for a smoking ban in hospitals, research facilities, and health-care clinics as well as in public places, states a comment published online today by The Lancet to coincide with World No Tobacco Day.

31 May 2005

Nastech Pharmaceutical awarded new breast cancer patent

Nastech Pharmaceutical Company today announced that it has been awarded U.S. patent No. 6,894,026, entitled, "Long-acting Oxytocin Analogues for the Treatment and Prevention of Breast Cancer and Psychiatric Disorders."

31 May 2005

Targepeutics issued new U.S patent

Targepeutics has announced the issuance of U.S. Patent No. 6,884,603 for its genetically modified, mutated Interleukin 13 (IL-13) technology platform for the treatment of malignant glioma, a brain tumor (17,500 people annually; $200 million annual market).

31 May 2005

Under prescribing of statins puts more people at risk of premature death

A new study out of Stanford School of Medicine says that cholesterol-lowering drugs known as statins that can help prevent heart disease are still underprescribed for many at-risk patients.

31 May 2005

Tobacco companies used psychological means to deliberately target women

Health researchers have revealed this week that tobacco companies specifically designed cigarettes to appeal to women's desires to be thin and healthy in ways that went "far beyond marketing and advertising".

31 May 2005

Baby boy is first successful birth in Canada from frozen eggs

McGill University Health Center (MUHC) in Montreal yesterday announced the first successful birth in Canada resulting from frozen eggs. A healthy baby boy, weighing 3740 grams was born on April 29 to a 26-year-old mother who had suffered from infertility for two years.

31 May 2005

Exposure to pharmaceutical estrogen during fetal development can permanently "reprogram" tissue in a way that determines whether tumors will develop in adulthood

Researchers at The University of Texas M. D. Anderson Cancer Center may have uncovered the reason why some people who are genetically predisposed to hormone-dependent cancers develop the disease as an adult, while others who are similarly susceptible don't.

30 May 2005

Ibuprofen use is associated with an increased risk of breast cancer

Ibuprofen use is associated with an increased risk of breast cancer, and long-term daily use of aspirin is associated with an increased risk of estrogen receptor/progesterone receptor (ER/PR)-negative breast cancer, according to a new study in the June 1 issue of the Journal of the National Cancer Institute.

30 May 2005

Young adults forget their own life-support decisions

More than half of young adults soon unwittingly change their minds about decisions they make governing future life-saving medical treatment for themselves, a new study has found.

30 May 2005

New understanding of DNA repair processes may pave way to cancer treatments

A Burnham Institute study has found that a protein known for its role in gene regulation has another important function, that of initiating DNA repair. The study, published in the May 27th edition of Molecular Cell, points to new targets for treatment of cancer.

30 May 2005

Chemicals in food packaging linked to breast cancer

Chemicals found in some food packaging materials have been shown in a new study to affect the development of breast tissue in mice, which suggests, say scientists, that women exposed to such chemicals, which mimic female hormones, may be at increased risk of breast cancer.

30 May 2005

Bioniche Life Sciences granted European patent

Bioniche Life Sciences has announced that it has had another patent granted on its core technology: Mycobacterial Cell Wall-DNA Complex (MCC). The European Patent Organization (EPO) granted the patent: - "Composition and Method for Inducing Apoptosis in Prostate Cancer Cells" (EPO1165106)

30 May 2005

Technology for analyzing gene expression must be standardized

Technology for analyzing gene expression must be standardized among laboratories and across platforms around the world to support this age of human genome exploration, an Oregon Health & Science University researcher says.

29 May 2005